Market Overview
The Surgical Sutures Market is projected to grow from USD
4.1 Billion in 2023 to USD 6.0 Billion by 2032, exhibiting a CAGR of 4.90%
during the forecast period (2023 - 2032).
Market Dynamics
Market expansion is being fueled by a
number of factors, including an increase in the number of patients admitted to
hospitals with chronic conditions, a more generous payment environment, and an
increase in the number of trauma cases. There has been an uptick in both the
incidence of trauma and the number of individuals admitted to hospitals with
long-term conditions. The need for surgical sutures is expected to rise as the
number of surgical procedures requiring suturing increases, particularly those involving
the musculoskeletal system, the digestive system, the eyes, and other areas.
Consequently, the growth of the market for surgical sutures was positively
influenced by the rising number of surgical procedures.
Demand for bariatric treatments is rising
as the percentage of obese people in the population rises. As a result, there
is a greater need for surgical sutures in bariatric surgeries, driving market
growth. Market growth during the forecast period could be aided by the
proliferation of hospitals and ASCs that offer advanced
surgical suturing techniques.
The growth of the market is also expected
to be fueled by the aging population. The rise in fatal car accidents is seen
as a growth opportunity for the industry. Due to other crucial variables such
as increasing urbanization and disposable income, the market for surgical sutures
will grow at a slower rate. Good reimbursement conditions and increased
healthcare infrastructure spending will fuel the growth of the surgical suture
market. Consequently, fueling business in the Surgical Sutures industry.
Market Segmentation
Surgical suture markets can be broken down
into two categories: absorbable and non-absorbable.
The filament segment is divided the market
into monofilament and multifilament subsets.
The market segmentation of Surgical
Sutures, based on Application, includes ophthalmic surgery, cardiovascular
surgery, orthopedic surgery, neurological surgery, and others.
Regional Analysis
In 2022, North America held a 45.80% share
of the global surgical sutures market. This was largely due to the region's
abundance of key players, favorable reimbursement policies, expanding public
health initiatives, and well-established healthcare infrastructure. North
America's substantial revenue share can also be attributed in large part to the
region's advanced technology and robust domestic wealth. Canada's Surgical
Sutures market is expanding at twice the rate of the U.S. market, and the North
American market as a whole is growing at twice the rate of the rest of the
world.
In 2022, the European market for surgical
sutures was by far the largest. This is because of the growing prevalence of
chronic diseases among the elderly, which in turn increases the demand for
surgical sutures. As a result, it's expected that the local market will expand.
In addition, Germany was the largest market for surgical sutures, while the
United Kingdom was the fastest expanding market in Europe.
From 2023 to 2032, the market for surgical
sutures is projected to expand at a rate highest in Asia Pacific. This is due
to an increase in the older population, who are more likely to require surgical
intervention, and an increase in government spending on the healthcare system
to meet the increased demand. China, India, and Japan are three of the most
important markets in the Asia Pacific area. The growth of medical tourism to
countries like India, Singapore, and Malaysia is also a major factor in the exponential
expansion of this sector. Furthermore, China's Surgical Sutures market retained
the greatest market share, while India's Surgical Sutures market grew at the
quickest rate in the Asia-Pacific region.
Competitive Analysis
The Global Surgical Sutures Market Players including Covidien, Ethicon US,
LLC. (Johnson & Johnson Services, Inc.), B. Braun Melsungen AG, Smith &
Nephew, Integra Lifesciences, Peter Surgical, Internacional farmaceutica,
CONMED CORPORATION, and Sutures India Pvt. Ltd., are attempting to increase
market demand by investing in research and development operations.
Global Blue Biotechnology Market
Healthcare Revenue Cycle Management Market
0 Comments